0001193125-24-196457.txt : 20240808 0001193125-24-196457.hdr.sgml : 20240808 20240808070029 ACCESSION NUMBER: 0001193125-24-196457 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240808 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Galera Therapeutics, Inc. CENTRAL INDEX KEY: 0001563577 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 461454898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39114 FILM NUMBER: 241185941 BUSINESS ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: 610-725-1500 MAIL ADDRESS: STREET 1: 45 LIBERTY BLVD. STREET 2: SUITE 230 CITY: MALVERN STATE: PA ZIP: 19355 8-K 1 d792052d8k.htm 8-K 8-K
NONE false 0001563577 0001563577 2024-08-08 2024-08-08

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): August 8, 2024

 

 

GALERA THERAPEUTICS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39114   46-1454898

(State or other jurisdiction of

incorporation or organization)

  

(Commission

File Number)

  

(I.R.S. Employer

Identification No.)

45 Liberty Blvd #230

Malvern, PA 19355

(Address of principal executive offices) (Zip Code)

(610) 725-1500

(Registrant’s telephone number, include area code)

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Stock, $0.001 par value per share   GRTX   OTC Pink Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☒

 

 

 

Item 7.01 Regulation FD Disclosure.

On May 30, 2023, Galera Therapeutics, Inc. (the “Company”) filed a lawsuit in the Court of Common Pleas in Chester County, Pennsylvania, or the Court, against Alira Health Clinical, LLC and IQVIA Biotech, LLC, (the “CROs”), seeking damages and alleging breach of contract, professional negligence, and negligence related to an error by the defendants in 2021 in their statistical program for the Phase 3 ROMAN trial of avasopasem for the reduction of severe oral mucositis induced by radiotherapy in patients with locally advanced head and neck cancer (the Phase 3 ROMAN trial) (the “Litigation”). Galera and the CROs have entered into an agreement to settle the Litigation, pursuant to which, in exchange for mutual releases, the CROs have paid to Galera the amount of $975,000, and the parties have terminated the contracts between Galera and the CROs, with no further obligations under the parties’ contracts. The Company expects to file a Praecipe to Settle, Discontinue, and End the Litigation on or before August 8, 2024.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    GALERA THERAPEUTICS, INC.
Date: August 8, 2024     By:  

/s/ J. Mel Sorensen, M.D.

      J. Mel Sorensen, M.D.
      President and Chief Executive Officer
 EX-101.SCH 2 grtx-20240808.xsd XBRL TAXONOMY EXTENSION SCHEMA 000001 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 3 grtx-20240808_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address Address Line 1 Entity Address Address Line 1 Entity Address City Or Town Entity Address City Or Town Entity Address State Or Province Entity Address State Or Province Entity Address Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key EX-101.PRE 4 grtx-20240808_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Document and Entity Information
Aug. 08, 2024
Cover [Abstract]  
Document Type 8-K
Document Period End Date Aug. 08, 2024
Entity Registrant Name GALERA THERAPEUTICS, INC.
Entity Incorporation State Country Code DE
Entity File Number 001-39114
Entity Tax Identification Number 46-1454898
Entity Address Address Line 1 45 Liberty Blvd #230
Entity Address City Or Town Malvern
Entity Address State Or Province PA
Entity Address Postal Zip Code 19355
City Area Code 610
Local Phone Number 725-1500
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Stock, $0.001 par value per share
Trading Symbol GRTX
Security Exchange Name NONE
Entity Emerging Growth Company true
Entity Ex Transition Period true
Amendment Flag false
Entity Central Index Key 0001563577
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2.u1 html 1 23 1 false 0 0 false 0 false false R1.htm 000001 - Document - Document and Entity Information Sheet http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d792052d8k.htm grtx-20240808.xsd grtx-20240808_lab.xml grtx-20240808_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d792052d8k.htm": { "nsprefix": "grtx", "nsuri": "http://www.galeratx.com/20240808", "dts": { "inline": { "local": [ "d792052d8k.htm" ] }, "schema": { "local": [ "grtx-20240808.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "grtx-20240808_lab.xml" ] }, "presentationLink": { "local": [ "grtx-20240808_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "000001 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-08-08_to_2024-08-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d792052d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-08-08_to_2024-08-08", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d792052d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Address Line 1", "terseLabel": "Entity Address Address Line 1", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address City Or Town", "terseLabel": "Entity Address City Or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "terseLabel": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.galeratx.com//20240808/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 15 0001193125-24-196457-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-196457-xbrl.zip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end XML 16 d792052d8k_htm.xml IDEA: XBRL DOCUMENT 0001563577 2024-08-08 2024-08-08 NONE false 0001563577 8-K 2024-08-08 GALERA THERAPEUTICS, INC. DE 001-39114 46-1454898 45 Liberty Blvd #230 Malvern PA 19355 610 725-1500 false false false false Common Stock, $0.001 par value per share GRTX true true